“Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate,” news release, Aktis Oncology Inc. Editor’s note: This article is for …
FDA OKs Fast Track to AKY-1189 in Metastatic Urothelial Cancer – CURE
About the Author: AJDesign77
“Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate,” news release, Aktis Oncology Inc. Editor’s note: This article is for …